Results 181 to 190 of about 7,269,468 (262)

LBO2 Long-term renal and cardiovascular risks of tacrolimus in lupus nephritis patients

Lupus Science and Medicine
Obbo W Bredewold, Ton J Rabelink, YK Onno Teng, Joris I Rotmans, Mieke van Schaik, Merel Priester, Wieneke M Michels   +6 more
doaj   +1 more source

Prevalence of systemic disease among COVID-19 patients admitted at Jumbo COVID care facility, Mumbai. [PDF]

Bioinformation
Kshirsagar MM, A M S, Deshmukh M, Mishra P, Mane S, Kapade P, Sankhla B.   +6 more
europepmc   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source

The Oral Cavity as a Window to Systemic Disease: Diagnostic Clues and Pre-treatment Dental Management for Interdisciplinary Trainees. [PDF]

Cureus
Sarbeland L, Sultani MY, Afzalzada N, Latifi F, Ali S, Muradi M, Elmyar AH, Sultani MI, Yousofi T, Sharify M, Kamran Qadiri R, Naziri Sarir N, Sadat Sultany H.   +12 more
europepmc   +1 more source

Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To identify inflammatory analytes in cerebrospinal fluid (CSF) and plasma associated with cognitive decline in cognitively normal (CN) older adults at risk for Alzheimer's disease (AD). Methods In a longitudinal study of 118 CN older adults (65–80 years, 54% APOE ε4, 26% preclinical AD), 1331 CSF and 1501 plasma analytes were ...
Jagan A. Pillai, Audrey Zhu, Chunxuan Ma, Ming Wang, Yifan Yang, Lynn M. Bekris, Maria Khrestian, Frank P. DiFilippo, Mikhail Nasrallah, Aaron Burberry, James B. Leverenz, Yuan Hou, Feixiong Cheng, Stephen M. Rao   +13 more
wiley   +1 more source

Obesity as a Systemic Disease: Metabolic Benefits of Modest Weight Reduction in Specific Health Guidance-Eligible Individuals. [PDF]

Circ Rep
Hara T.
europepmc   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Five-Year Outcomes of Transforaminal Endoscopic Lumbar Decompression for Lateral Recess Stenosis in Patients With Chronic Systemic Disease. [PDF]

Int J Spine Surg
Kapetanakis S, Chatzivasiliadis M, Siopis C, Konstantinou P, Tsioulas P, Ditsios K.   +5 more
europepmc   +1 more source

microRNA‐7‐5p and α‐Synuclein SAA Predict Parkinson's Disease Phenoconversion

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corroborate blood neuron‐derived extracellular vesicle (NDEV) alpha‐synuclein (αSyn), the CSF αSyn seed amplification assay (αSyn‐SAA), and blood microRNA‐7‐5p (miR‐7‐5p) as markers for Parkinson's disease (PD) phenoconversion and determine if combining these markers would help select subjects who would be more likely to phenoconvert.
Shayan Zadegan, Praveen Velammal, Kanmani Muthiah, Madhu Jatty, Christopher Adams   +4 more
wiley   +1 more source

Compressive Coronary Hematoma Treated With Stenting: From Early Malapposition to 9-Year Recovery in Systemic Disease. [PDF]

JACC Case Rep
Ouerghi K, Fabre C, Lazizi T, Mateus V, Furber A, Willoteaux S, Bière L, Prunier F.   +7 more
europepmc   +1 more source